Abstract |
Hepatoerythropoietic porphyria (HEP) is an inherited metabolic disorder characterized by the accumulation of porphyrins resulting from a deficiency in uroporphyrinogen decarboxylase (UROD). This autosomal recessive disorder is severe, starting early in infancy with no specific treatment. Gene therapy would represent a great therapeutic improvement. Because hematopoietic cells are the target for somatic gene therapy in this porphyria, Epstein-Barr virus-transformed B-cell lines from patients with HEP provide a model system for the disease. Thus, retrovirus-mediated expression of UROD was used to restore enzymatic activity in B-cell lines from 3 HEP patients. The potential of gene therapy for the metabolic correction of the disease was demonstrated by a reduction of porphyrin accumulation to the normal level in deficient transduced cells. Mixed culture experiments demonstrated that there is no metabolic cross-correction of deficient cells by normal cells. However, the observation of cellular expansion in vitro and in vivo in immunodeficient mice suggested that genetically corrected cells have a competitive advantage. Finally, to facilitate future human gene therapy trials, we have developed a selection system based on the expression of the therapeutic gene. Genetically corrected cells are easily separated from deficient ones by the absence of fluorescence when illuminated under UV light.
|
Authors | A Fontanellas, F Mazurier, F Moreau-Gaudry, F Belloc, C Ged, H de Verneuil |
Journal | Blood
(Blood)
Vol. 94
Issue 2
Pg. 465-74
(Jul 15 1999)
ISSN: 0006-4971 [Print] United States |
PMID | 10397714
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Uroporphyrinogen Decarboxylase
|
Topics |
- Animals
- B-Lymphocytes
(enzymology, transplantation)
- Cell Line, Transformed
- Cell Transformation, Viral
- Coculture Techniques
- Flow Cytometry
- Genetic Therapy
- Herpesvirus 4, Human
- Humans
- Male
- Mice
- Mice, Mutant Strains
- Microscopy, Fluorescence
- Porphyria, Hepatoerythropoietic
(enzymology, genetics, therapy)
- Selection, Genetic
- Transfection
- Ultraviolet Rays
- Uroporphyrinogen Decarboxylase
(deficiency, genetics)
|